Well Differentiated Pancreatic Endocrine Tumor
1 clinical trials · Condition
◉ Watch Well Differentiated Pancreatic Endocrine Tumor
| Record | Firm | Date |
|---|---|---|
| Activity and Safety of Everolimus+Octreotide LAR+Metformin in Advanced Pancreatic Well-differentiated NETs (NCT02294006) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2014-06-01 |
Track Well Differentiated Pancreatic Endocrine Tumor automatically
Every clearance here is in the API, with alerts when new ones post.